Justin Shields

1.4k total citations
12 papers, 743 citations indexed

About

Justin Shields is a scholar working on Infectious Diseases, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Justin Shields has authored 12 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Justin Shields's work include SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (3 papers) and Hepatitis C virus research (3 papers). Justin Shields is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (3 papers) and Hepatitis C virus research (3 papers). Justin Shields collaborates with scholars based in Canada, Taiwan and New Zealand. Justin Shields's co-authors include D. Lorne Tyrrell, Michael Joyce, Elena Arutyunova, Holly A. Saffran, M. Joanne Lemieux, Muhammad Bashir Khan, Howard S. Young, John C. Vederas, Wayne Vuong and Tess Lamer and has published in prestigious journals such as Nature Communications, Gut and Journal of Hepatology.

In The Last Decade

Justin Shields

11 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Shields Canada 9 353 288 252 107 93 12 743
Amy Fung United States 9 214 0.6× 94 0.3× 361 1.4× 124 1.2× 254 2.7× 10 920
Brit J. Hart United States 7 753 2.1× 181 0.6× 254 1.0× 52 0.5× 137 1.5× 8 1.1k
Shin-ichiro Hattori Japan 16 269 0.8× 106 0.4× 204 0.8× 128 1.2× 114 1.2× 36 715
Carolina Q. Sacramento Brazil 16 438 1.2× 119 0.4× 318 1.3× 156 1.5× 106 1.1× 34 920
Jacob D. Johnson United States 23 144 0.4× 222 0.8× 404 1.6× 213 2.0× 175 1.9× 41 1.5k
Kevin R. Alliston United States 21 521 1.5× 171 0.6× 300 1.2× 319 3.0× 88 0.9× 38 1.2k
Adeyemi O. Adedeji United States 14 504 1.4× 180 0.6× 339 1.3× 37 0.3× 77 0.8× 39 986
Joël Mosnier France 18 247 0.7× 210 0.7× 168 0.7× 192 1.8× 55 0.6× 50 964
Jairo R. Temerozo Brazil 17 380 1.1× 109 0.4× 324 1.3× 60 0.6× 91 1.0× 35 875
Arif Ali China 13 297 0.8× 257 0.9× 404 1.6× 46 0.4× 52 0.6× 24 747

Countries citing papers authored by Justin Shields

Since Specialization
Citations

This map shows the geographic impact of Justin Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Shields more than expected).

Fields of papers citing papers by Justin Shields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Shields. The network helps show where Justin Shields may publish in the future.

Co-authorship network of co-authors of Justin Shields

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Shields. A scholar is included among the top collaborators of Justin Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Shields. Justin Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Joyce, Michael, et al.. (2024). Peptide Aldehydes Incorporating Thiazol-4-yl Alanine Are Potent In Vitro Inhibitors of SARS-CoV-2 Main Protease. ACS Medicinal Chemistry Letters. 15(11). 2046–2052.
2.
Law, John Lok Man, Michael Logan, Michael Joyce, et al.. (2021). SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine. 39(40). 5769–5779. 24 indexed citations
3.
Vuong, Wayne, Conrad Fischer, Muhammad Bashir Khan, et al.. (2021). Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. European Journal of Medicinal Chemistry. 222. 113584–113584. 65 indexed citations
4.
Shahbaz, Shima, Lai Xu, Mohammed Osman, et al.. (2021). Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Reports. 16(5). 1165–1181. 76 indexed citations
5.
Bai, Bing, Elena Arutyunova, Muhammad Bashir Khan, et al.. (2021). Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. RSC Medicinal Chemistry. 12(10). 1722–1730. 37 indexed citations
6.
Vuong, Wayne, Muhammad Bashir Khan, Conrad Fischer, et al.. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications. 11(1). 4282–4282. 340 indexed citations
7.
Liu, Ching‐Hsuan, Chun‐Ching Lin, Chih‐Chan Lin, et al.. (2016). Highly bioavailable silibinin nanoparticles inhibit HCV infection. Gut. 66(10). 1853–1861. 43 indexed citations
8.
Lin, Liang, Justin Shields, Rodney S. Russell, et al.. (2014). Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Journal of Hepatology. 62(3). 541–548. 86 indexed citations
9.
Neufeldt, Christopher J., Michael Joyce, Aviad Levin, et al.. (2013). Hepatitis C Virus-Induced Cytoplasmic Organelles Use the Nuclear Transport Machinery to Establish an Environment Conducive to Virus Replication. PLoS Pathogens. 9(10). e1003744–e1003744. 47 indexed citations
10.
11.
Shields, Justin, et al.. (2012). Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression. Investigational New Drugs. 30(6). 2236–2251. 8 indexed citations
12.
Zhao, Li, Justin Shields, & D. Lorne Tyrrell. (2010). Functional changes, increased apoptosis, and diminished nuclear factor–κB activity of myeloid dendritic cells during chronic hepatitis C infection. Human Immunology. 71(8). 751–762. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Fung Breakdown of academic impact, for papers by Brit J. Hart Breakdown of academic impact, for papers by Shin-ichiro Hattori Breakdown of academic impact, for papers by Carolina Q. Sacramento Breakdown of academic impact, for papers by Jacob D. Johnson Breakdown of academic impact, for papers by Kevin R. Alliston Breakdown of academic impact, for papers by Adeyemi O. Adedeji Breakdown of academic impact, for papers by Joël Mosnier Breakdown of academic impact, for papers by Jairo R. Temerozo Breakdown of academic impact, for papers by Arif Ali
Rankless by CCL
2026